We desperately need antivirals that are as broad spectrum as antibacterials, so this research may be encouraging to watch:.
News article: gizmag.com/ibm-macromolecul...
Paper: pubs.acs.org/doi/abs/10.102...
Neil
IBM-developed macromolecule uses triple-attack... - CLL Support
IBM-developed macromolecule uses triple-attack technique to fight deadly viruses
AussieNeilPartnerAdministrator
Written by
AussieNeil
Partner
To view profiles and participate in discussions please or .
Not what you're looking for?
You may also like...
CLL story in the Northern Echo UK
http://www.thenorthernecho.co.uk/news/15607122.Sharing_her_journey__blood_cancer_patient_tells_her_
Latest results and musing on my own blood work
habit of posting my personal news and musings on my own results on my blog...
Three Year Anniversary on Ibrutinib for my CLL
new website: http://cllsociety.org
Stay strong.
We are all in this together.
Brian...
NICE u turn after Roche drug price negotiations
Excellent news re: Gazyvaro!!
http://m.bbc.co.uk/news/uk-wales-30274804
NICE press release added...
HAPPY NEW YEAR WISHES for 2013
Imbruvica adverse effects. 
